Led by Luis Casas, MD, the TrialNet team at Sanford Health is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Sanford Health is regionally overseen by University of Minnesota. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Daniel Flynn, MD, the TrialNet team at St. Lukes Humphreys Diabetes Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, St. Lukes Humphreys Diabetes Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Stanford University is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Darrell Wilson, MD, the TrialNet team at Stanford University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.   

Led by Maria Contreras, MD, the TrialNet team at Texas Tech University Health Sciences Center at Amarillo is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Texas Tech University Health Sciences Center is regionally overseen by University of Texas Southwestern. If you reach out to TrialNet, you may be contacted by staff from either institution. 

The Hospital for Sick Children (SickKids) is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Diane Wherrett, MD, the TrialNet team at SickKids is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Led by Dr. Jay Shubrook, DO, the TrialNet team at Touro University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Touro University is regionally overseen by University of California - San Francisco. If you reach out to TrialNet, you may be contacted by staff from either institution. 

University of California, San Francisco (UCSF) is one of eighteen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Stephen Gitelman, MD, the TrialNet team at UCSF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Principal Investigator, Lou Philipson, MD, the TrialNet team at the University of Chicago is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Chicago is regionally overseen by Indiana University - Riley Hospital. If you reach out to TrialNet, you may be contacted by staff from either institution. 

The University of Florida (UF) is one of eighteen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Michael Haller, MD, the TrialNet team at UF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by David Baidal, MD, the TrialNet team at University of Miami is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Note: As a TrialNet affiliate, University of Miami is regionally overseen by University of Florida. If you reach out to TrialNet, you may be contacted by staff from either institution.